Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration
Data(s) |
01/09/2006
|
---|---|
Identificador |
http://dx.doi.org/10.1016/j.ophtha.2006.02.064 http://www.scopus.com/inward/record.url?scp=33747891752&partnerID=8YFLogxK |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Chakravarthy , U , Adamis , A P , Jr , C E T , Goldbaum , M , Guyer , D R , Katz , B & Patel , M 2006 , ' Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration ' Ophthalmology , vol 113 (9) , no. 9 , pp. 1508-1521 . DOI: 10.1016/j.ophtha.2006.02.064 |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2731 #Ophthalmology |
Tipo |
article |